Cosmetic Surgery And Procedures Market Report
Cosmetic Surgery and Procedures Market, By Type (Surgical (Breast Surgery, Body and Extremities, Face Surgery), Nonsurgical (Injectables, Facial Rejuvenation, Others)), End-User (Hospitals, Office-based Facilities, Ambulatory Surgical Centers), and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Cosmetic Surgery and Procedures market. The historic years considered for the study are 2016-2019, the base year is 2020, and the forecast period is 2021-2026.
Cosmetic Surgery and Procedures Market, By Type (Surgical (Breast Surgery, Body and Extremities, Face Surgery), Nonsurgical (Injectables, Facial Rejuvenation, Others)), End-User (Hospitals, Office-based Facilities, Ambulatory Surgical Centers), and Region...
Impact of COVID-19 on Cosmetic Surgery And Procedures Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Cosmetic Surgery and Procedures market is projected to grow from USD 26.3 billion in 2020 to USD 36.1 billion by 2026 at a CAGR of around 5.5% during the forecast period.
Cosmetic surgery is defined as a process that enhances a portion of an individual’s body or, faces through the incision. Cosmetic surgeries include altering facial structure (maxillofacial), reconstruction or reshaping of body parts, and altering the structure of the jaw (craniofacial) among others.
Key players operating in the Cosmetic Surgery and Procedures Market are-
The growth of the cosmetic surgery and procedures market is primarily driven by an increasing number of cosmetic surgeries across geographies. Growing consciousness among consumers related to personal aesthetics coupled with rising per capita disposable income of the consumers is expected to propel the market growth at a significant rate during the review period. Additionally, a growing emphasis on research and development activities to develop advanced surgical procedures is likely to create lucrative opportunities for the market players during the review period.
By end-user, the cosmetic surgery and procedures market has been bifurcated into hospitals, office-based facilities, and ambulatory surgical centers. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of skin disorders coupled with the presence of key market players such as Genesis Biosystems (US) and A.P. Pharma, Inc. (US). The market growth in the Asia-Pacific region is expected to be driven by increased spending on cosmetic surgeries and rising medical tourism.
The outbreak of the COVID-19 virus has affected the growth of the healthcare industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply for a short period and thus, affected the market growth.
Here is the list of the group of customers that the cosmetic surgery and procedures market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at firstname.lastname@example.org.
The cosmetic surgery and procedures market is expected to witness an impressive growth of 5.5% CAGR in the coming years.
Sanofi S.A. (France), Bausch Health Companies Inc. (Canada), Lumenis (Israel), Genesis Biosys-tems (US), Covidien (Ireland), A.P. Pharma, Inc. (US), Zeltiq Aesthetics (US), Cynosure (US), Al-lergan, Inc. (Ireland), Merz Pharma GmbH & Co. KGaA (Germany), Cutera, Inc. (US), Ipsen (France), Sientra (US), ALMA LASERS LTD. (Israel) and Johnson & Johnson (US) are among the key players in the cosmetic surgery and procedures market.
The cosmetic surgery and procedures market size is expected to reach USD 36.1 billion in the foreseeable future.
The hospitals' segment is expected to register significant growth in the cosmetic surgery and procedures market in the coming years.
North America accounted for the largest share in the cosmetic surgery and procedures market in 2020.
Cosmetic surgery and procedures distributors, Cosmetic surgery and procedures suppliers, Cosmetic surgery and procedures manufacturers, Logistics organizations, Government bodies are the target audience in the cosmetic surgery and procedures market.